-
1
-
-
0025981467
-
Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
-
Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
-
(1991)
Prev Med
, vol.20
, pp. 47-63
-
-
Stampfer, M.J.1
Colditz, G.A.2
-
2
-
-
0028279044
-
A study of the association between hormone replacement therapy, smoking, and the occurrence of myocardial infarction in women
-
Mann RD, Lis Y, Chukwujindu J, Chanter DO. A study of the association between hormone replacement therapy, smoking, and the occurrence of myocardial infarction in women. J Clin Epidemiol 1994;47:307-312.
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 307-312
-
-
Mann, R.D.1
Lis, Y.2
Chukwujindu, J.3
Chanter, D.O.4
-
3
-
-
0030995532
-
Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women
-
Heckbert SR, Weiss NS, Koepsell TD, Lemaitre RN, Smith NL, Siscovick DS, Lin D, Psaty BM. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch Intern Med 1997;157:1330-1336.
-
(1997)
Arch Intern Med
, vol.157
, pp. 1330-1336
-
-
Heckbert, S.R.1
Weiss, N.S.2
Koepsell, T.D.3
Lemaitre, R.N.4
Smith, N.L.5
Siscovick, D.S.6
Lin, D.7
Psaty, B.M.8
-
4
-
-
0029759025
-
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
-
Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
-
(1996)
N Engl J Med
, vol.335
, pp. 453-461
-
-
Grodstein, F.1
Stampfer, M.J.2
Manson, J.E.3
Colditz, G.A.4
Willett, W.C.5
Rosner, B.6
Speizer, F.E.7
Hennekens, C.H.8
-
5
-
-
0034710639
-
Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women
-
Hu FB, Stampfer MJ, Manson JE, Grodstein F, Colditz GA, Speizer FE, Willett C. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530-537.
-
(2000)
N Engl J Med
, vol.343
, pp. 530-537
-
-
Hu, F.B.1
Stampfer, M.J.2
Manson, J.E.3
Grodstein, F.4
Colditz, G.A.5
Speizer, F.E.6
Willett, C.7
-
6
-
-
0029056755
-
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
-
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-1593.
-
(1995)
N Engl J Med
, vol.332
, pp. 1589-1593
-
-
Colditz, G.A.1
Hankinson, S.E.2
Hunter, D.J.3
Willett, W.C.4
Manson, J.E.5
Stampfer, M.J.6
Hennekens, C.7
Rosner, B.8
Speizer, F.E.9
-
7
-
-
0034716353
-
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
-
Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485-491.
-
(2000)
JAMA
, vol.283
, pp. 485-491
-
-
Schairer, C.1
Lubin, J.2
Troisi, R.3
Sturgeon, S.4
Brinton, L.5
Hoover, R.6
-
9
-
-
0031154137
-
Tibolone: Influence on markers of cardiovascular disease
-
Bjarnason NH, Bjarnason K, Haarbo J, Bennink HJ, Christiansen C. Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab 1997;82:1752-1756.
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 1752-1756
-
-
Bjarnason, N.H.1
Bjarnason, K.2
Haarbo, J.3
Bennink, H.J.4
Christiansen, C.5
-
10
-
-
0037234656
-
Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux
-
von Eckardstein A, Crook D, Elbers J, Ragoobir J, Ezeh B, Helmond F, Miller N, Dieplinger H, Bennink HC, Assmann G. Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux. Clin Endocrinol (Oxf) 2003;58:49-58.
-
(2003)
Clin Endocrinol (Oxf)
, vol.58
, pp. 49-58
-
-
Von Eckardstein, A.1
Crook, D.2
Elbers, J.3
Ragoobir, J.4
Ezeh, B.5
Helmond, F.6
Miller, N.7
Dieplinger, H.8
Bennink, H.C.9
Assmann, G.10
-
11
-
-
0346221351
-
The Osteoporosis Prevention and Arterial effects of TiboLone (OPAL) study: Design and baseline characteristics
-
Bots ML, Evans GW, Riley W, Meijer R, McBride KH, Paskett ED, Helmond FA, Grobbee DE; OPAL Investigators.The Osteoporosis Prevention and Arterial effects of TiboLone (OPAL) study: design and baseline characteristics. Control Clin Trials 2003;24:752-775.
-
(2003)
Control Clin Trials
, vol.24
, pp. 752-775
-
-
Bots, M.L.1
Evans, G.W.2
Riley, W.3
Meijer, R.4
McBride, K.H.5
Paskett, E.D.6
Helmond, F.A.7
Grobbee, D.E.8
-
12
-
-
0028799383
-
Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study
-
Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 1995;142:1011-1019.
-
(1995)
Am J Epidemiol
, vol.142
, pp. 1011-1019
-
-
Espeland, M.A.1
Applegate, W.2
Furberg, C.D.3
Lefkowitz, D.4
Rice, L.5
Hunninghake, D.6
-
13
-
-
0026718680
-
Analysis strategies for serial multivariate ultrasonographic data that are incomplete
-
Espeland MA, Byington RP, Hire D, Davis VG, Hartwell T, Probstfield J. Analysis strategies for serial multivariate ultrasonographic data that are incomplete. Stat Med 1992;11:1041-1056.
-
(1992)
Stat Med
, vol.11
, pp. 1041-1056
-
-
Espeland, M.A.1
Byington, R.P.2
Hire, D.3
Davis, V.G.4
Hartwell, T.5
Probstfield, J.6
-
14
-
-
0036919684
-
Carotid intima-media thickness, arterial stiffness, and risk of cardiovascular disease: Current evidence
-
Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness, and risk of cardiovascular disease: current evidence. J Hypertens 2002;20:2317-2325.
-
(2002)
J Hypertens
, vol.20
, pp. 2317-2325
-
-
Bots, M.L.1
Dijk, J.M.2
Oren, A.3
Grobbee, D.E.4
-
15
-
-
0032519844
-
The role of carotid arterial intima-media thickness in predicting clinical coronary events
-
Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269.
-
(1998)
Ann Intern Med
, vol.128
, pp. 262-269
-
-
Hodis, H.N.1
Mack, W.J.2
LaBree, L.3
Selzer, R.H.4
Liu, C.R.5
Liu, C.H.6
Azen, S.P.7
-
16
-
-
33644916358
-
AHA Prevention Conference V Writing Group III on Noninvasive Tests of Atherosclerotic Burden
-
AHA Prevention Conference V Writing Group III on Noninvasive Tests of Atherosclerotic Burden. Circulation 2000;101:e16-e22.
-
(2000)
Circulation
, vol.101
-
-
-
17
-
-
0345167154
-
Carotid intima-media thickness measurements in intervention studies: Design options, progression rates, and sample size considerations: A point of view
-
Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 2003;34:2985-2994.
-
(2003)
Stroke
, vol.34
, pp. 2985-2994
-
-
Bots, M.L.1
Evans, G.W.2
Riley, W.A.3
Grobbee, D.E.4
-
18
-
-
0032785393
-
Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness
-
de Kleijn MJ, Bots ML, Bak AA, Westendorp IC, Planellas J, Coelingh Bennink HJ, Witteman JC, Grobbee DE. Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness. Maturitas 1999;32:195-204.
-
(1999)
Maturitas
, vol.32
, pp. 195-204
-
-
De Kleijn, M.J.1
Bots, M.L.2
Bak, A.A.3
Westendorp, I.C.4
Planellas, J.5
Coelingh Bennink, H.J.6
Witteman, J.C.7
Grobbee, D.E.8
-
19
-
-
0035144266
-
Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial
-
Angerer P, Stork S, Kothny W, Schmitt P, von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler Thromb Vasc Biol 2001;21:262-268.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 262-268
-
-
Angerer, P.1
Stork, S.2
Kothny, W.3
Schmitt, P.4
Von Schacky, C.5
-
20
-
-
0036791567
-
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy
-
Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, Riley W, Craven T, Chaput L, Ireland CC, Applegate WB; Heart and Estrogen/Progestin Replacement Study Research Group. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arterioscler Thromb Vasc Biol 2002;22:1692-1697.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1692-1697
-
-
Byington, R.P.1
Furberg, C.D.2
Herrington, D.M.3
Herd, J.A.4
Hunninghake, D.5
Lowery, M.6
Riley, W.7
Craven, T.8
Chaput, L.9
Ireland, C.C.10
Applegate, W.B.11
-
21
-
-
0035808009
-
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial
-
Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.
-
(2001)
Ann Intern Med
, vol.135
, pp. 939-953
-
-
Hodis, H.N.1
Mack, W.J.2
Lobo, R.A.3
Shoupe, D.4
Sevanian, A.5
Mahrer, P.R.6
Selzer, R.H.7
Liu Cr, C.R.8
Liu Ch, C.H.9
Azen, S.P.10
-
22
-
-
0033021377
-
High resolution ultrasound assessment of the carotid artery: Its relevance in post-menopausal women and the effects of tibolone on carotid artery ultrastructure
-
Morris EP, Denton ER, Robinson J, MacDonald LM, Rymer JM. High resolution ultrasound assessment of the carotid artery: its relevance in post-menopausal women and the effects of tibolone on carotid artery ultrastructure. Climacteric 1999;2:13-20.
-
(1999)
Climacteric
, vol.2
, pp. 13-20
-
-
Morris, E.P.1
Denton, E.R.2
Robinson, J.3
MacDonald, L.M.4
Rymer, J.M.5
-
23
-
-
1542267738
-
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women
-
Anedda FM, Velati A, Lello S, Orru M, Paoletti AM, Melis GB, Binaghi F. Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women. Horm Res 2004;61:47-52.
-
(2004)
Horm Res
, vol.61
, pp. 47-52
-
-
Anedda, F.M.1
Velati, A.2
Lello, S.3
Orru, M.4
Paoletti, A.M.5
Melis, G.B.6
Binaghi, F.7
-
24
-
-
0037307934
-
Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries
-
Erenus M, Ilhan AH, Elter K. Effect of tibolone treatment on intima-media thickness and the resistive indices of the carotid arteries. Fertil Steril 2003;79:268-273.
-
(2003)
Fertil Steril
, vol.79
, pp. 268-273
-
-
Erenus, M.1
Ilhan, A.H.2
Elter, K.3
-
25
-
-
0035108266
-
Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits
-
Zandberg P, Peters JLM, Demacker PN, de Reeder EG, Smit MJ, Meuleman DG. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause 2001;8:96-105.
-
(2001)
Menopause
, vol.8
, pp. 96-105
-
-
Zandberg, P.1
Peters, J.L.M.2
Demacker, P.N.3
De Reeder, E.G.4
Smit, M.J.5
Meuleman, D.G.6
-
26
-
-
0035198534
-
Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity
-
von Eckardstein A, Schmiddem K, Hovels A, Gulbahce E, Schuler-Luttmann S, Elbers J, Helmond F, Bennink HJ, Assmann G. Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity. Atherosclerosis 2001;159:433-439.
-
(2001)
Atherosclerosis
, vol.159
, pp. 433-439
-
-
Von Eckardstein, A.1
Schmiddem, K.2
Hovels, A.3
Gulbahce, E.4
Schuler-Luttmann, S.5
Elbers, J.6
Helmond, F.7
Bennink, H.J.8
Assmann, G.9
-
27
-
-
0035181597
-
A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys
-
Clarkson TB, Anthony MS, Wagner JD. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 2001;86:5396-5404.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5396-5404
-
-
Clarkson, T.B.1
Anthony, M.S.2
Wagner, J.D.3
-
28
-
-
0031702541
-
Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits
-
Zandberg P, Peters JL, Demacker PN, Smit MJ, de Reeder EG, Meuleman DG. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Arterioscler Thromb Vasc Biol 1998;18:1844-1854.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1844-1854
-
-
Zandberg, P.1
Peters, J.L.2
Demacker, P.N.3
Smit, M.J.4
De Reeder, E.G.5
Meuleman, D.G.6
-
29
-
-
0042093742
-
Estrogen plus progestin and the risk of coronary heart disease
-
Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M; Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534.
-
(2003)
N Engl J Med
, vol.349
, pp. 523-534
-
-
Manson, J.E.1
Hsia, J.2
Johnson, K.C.3
Rossouw, J.E.4
Assaf, A.R.5
Lasser, N.L.6
Trevisan, M.7
Black, H.R.8
Heckbert, S.R.9
Detrano, R.10
Strickland, O.L.11
Wong, N.D.12
Crouse, J.R.13
Stein, E.14
Cushman, M.15
-
30
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
-
Heart and Estrogen/progestin Replacement Study (HERS) Research Group
-
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
-
(1998)
JAMA
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
Furberg, C.4
Herrington, D.5
Riggs, B.6
Vittinghoff, E.7
-
31
-
-
0036754747
-
A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: The Papworth HRT atherosclerosis study
-
Clarke SC, Kelleher J, Lloyd-Jones H, Slack M, Schofiel PM. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study. BJOG 2002;109:1056-1062.
-
(2002)
BJOG
, vol.109
, pp. 1056-1062
-
-
Clarke, S.C.1
Kelleher, J.2
Lloyd-Jones, H.3
Slack, M.4
Schofiel, P.M.5
-
32
-
-
0035950682
-
A clinical trial of estrogen-replacement therapy after ischemic stroke
-
Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243-1249.
-
(2001)
N Engl J Med
, vol.345
, pp. 1243-1249
-
-
Viscoli, C.M.1
Brass, L.M.2
Kernan, W.N.3
Sarrel, P.M.4
Suissa, S.5
Horwitz, R.I.6
-
33
-
-
0037153707
-
Oestrogen therapy for prevention of reinfarction in postmenopausal women: A randomised placebo controlled trial
-
Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan MA, Kitchener H, McNamee R, Elstein M, Kay C, Seif M, Buckley H; ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 2002;360:2001-2008.
-
(2002)
Lancet
, vol.360
, pp. 2001-2008
-
-
Cherry, N.1
Gilmour, K.2
Hannaford, P.3
Heagerty, A.4
Khan, M.A.5
Kitchener, H.6
McNamee, R.7
Elstein, M.8
Kay, C.9
Seif, M.10
Buckley, H.11
-
34
-
-
0034710627
-
Effects of estrogen replacement on the progression of coronary artery atherosclerosis
-
Herrington D, Reboussin DM, Brosnihan KB, Sharp P, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med 2000;343:522-529.
-
(2000)
N Engl J Med
, vol.343
, pp. 522-529
-
-
Herrington, D.1
Reboussin, D.M.2
Brosnihan, K.B.3
Sharp, P.4
Shumaker, S.A.5
Snyder, T.E.6
Furberg, C.D.7
Kowalchuk, G.J.8
Stuckey, T.D.9
Rogers, W.J.10
Givens, D.H.11
Waters, D.12
-
35
-
-
0037145833
-
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial
-
Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002;288:2432-2440.
-
(2002)
JAMA
, vol.288
, pp. 2432-2440
-
-
Waters, D.D.1
Alderman, E.L.2
Hsia, J.3
Howard, B.V.4
Cobb, F.R.5
Rogers, W.J.6
Ouyang, P.7
Thompson, P.8
Tardif, J.C.9
Higginson, L.10
Bittner, V.11
Steffes, M.12
Gordon, D.J.13
Proschan, M.14
Younes, N.15
Verter, J.I.16
-
36
-
-
0042594633
-
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
-
Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco E, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH; Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535-545.
-
(2003)
N Engl J Med
, vol.349
, pp. 535-545
-
-
Hodis, H.N.1
Mack, W.J.2
Azen, S.P.3
Lobo, R.A.4
Shoupe, D.5
Mahrer, P.R.6
Faxon, D.P.7
Cashin-Hemphill, L.8
Sanmarco, E.9
French, W.J.10
Shook, T.L.11
Gaarder, T.D.12
Mehra, A.O.13
Rabbani, R.14
Sevanian, A.15
Shil, A.B.16
Torres, M.17
Vogelbach, K.H.18
Selzer, R.H.19
-
37
-
-
0035198396
-
The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris
-
Haines CJ, Yim SF, Sanderson JE.The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. Atherosclerosis 2001;159:467-470.
-
(2001)
Atherosclerosis
, vol.159
, pp. 467-470
-
-
Haines, C.J.1
Yim, S.F.2
Sanderson, J.E.3
-
38
-
-
0035199203
-
Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women
-
de Kleijn MJ, Wilmink HW, Bots ML, Bak AA, van der Schouw YT, Planellas J, Engelen S, Banga JD, Grobbee DE. Hormone replacement therapy and endothelial function. Results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 2001;159:357-365.
-
(2001)
Atherosclerosis
, vol.159
, pp. 357-365
-
-
De Kleijn, M.J.1
Wilmink, H.W.2
Bots, M.L.3
Bak, A.A.4
Van Der Schouw, Y.T.5
Planellas, J.6
Engelen, S.7
Banga, J.D.8
Grobbee, D.E.9
-
39
-
-
0035725454
-
A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: Effects on arterial compliance and endothelial function
-
Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Cravent R, McGrath BP. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol (Oxf) 2001;55:673-682.
-
(2001)
Clin Endocrinol (Oxf)
, vol.55
, pp. 673-682
-
-
Teede, H.J.1
Liang, Y.L.2
Kotsopoulos, D.3
Zoungas, S.4
Cravent, R.5
McGrath, B.P.6
-
40
-
-
0030848434
-
Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
-
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-494.
-
(1997)
Am J Epidemiol
, vol.146
, pp. 483-494
-
-
Chambless, L.E.1
Heiss, G.2
Folsom, A.R.3
Rosamond, W.4
Szklo, M.5
Sharrett, A.R.6
Clegg, L.X.7
-
41
-
-
0033938299
-
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: A multicenter, double-blind, randomized study
-
Winkler UH, Altkemper R, Kwee B, Helmond FA, Coelingh Bennink HJ. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertil Steril 2000;74:10-19.
-
(2000)
Fertil Steril
, vol.74
, pp. 10-19
-
-
Winkler, U.H.1
Altkemper, R.2
Kwee, B.3
Helmond, F.A.4
Coelingh Bennink, H.J.5
-
42
-
-
0037434599
-
Understanding the divergent data on postmenopausal hormone therapy
-
Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med 2003;348:645-650.
-
(2003)
N Engl J Med
, vol.348
, pp. 645-650
-
-
Grodstein, F.1
Clarkson, T.B.2
Manson, J.E.3
-
43
-
-
0036843384
-
Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys
-
Clarkson TB, Anthony MS, Mikkola TS, St Clair RW. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys. Stroke 2002;33:2700-2703.
-
(2002)
Stroke
, vol.33
, pp. 2700-2703
-
-
Clarkson, T.B.1
Anthony, M.S.2
Mikkola, T.S.3
St Clair, R.W.4
|